Literature DB >> 15850662

Microglia and neuroprotection: implications for Alzheimer's disease.

Wolfgang J Streit1.   

Abstract

The first part of this paper summarizes some of the key observations from experimental work in animals that support a role of microglia as neuroprotective cells after acute neuronal injury. These studies point towards an important role of neuronal-microglial crosstalk in the facilitation of neuroprotection. Conceptually, injured neurons are thought to generate rescue signals that trigger microglial activation and, in turn, activated microglia produce trophic or other factors that help damaged neurons recover from injury. Against this background, the second part of this paper summarizes recent work from postmortem studies conducted in humans that have revealed the occurrence of senescent, or dystrophic, microglial cells in the aged and Alzheimer's disease brain. These findings suggest that microglial cells become increasingly dysfunctional with advancing age and that a loss of microglial cell function may involve a loss of neuroprotective properties that could contribute to the development of aging-related neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15850662     DOI: 10.1016/j.brainresrev.2004.12.013

Source DB:  PubMed          Journal:  Brain Res Brain Res Rev


  99 in total

1.  The GLP-1 analog, liraglutide prevents the increase of proinflammatory mediators in the hippocampus of male rat pups submitted to maternal perinatal food restriction.

Authors:  Y Diz-Chaves; L Toba; J Fandiño; L C González-Matías; L M Garcia-Segura; F Mallo
Journal:  J Neuroinflammation       Date:  2018-12-05       Impact factor: 8.322

Review 2.  Neuroinflammation in Huntington's disease.

Authors:  Thomas Möller
Journal:  J Neural Transm (Vienna)       Date:  2010-06-10       Impact factor: 3.575

3.  The Brain's Aging Immune System.

Authors:  Wolfgang J Streit; Qing-Shan Xue
Journal:  Aging Dis       Date:  2010-12-01       Impact factor: 6.745

Review 4.  Microglia and the control of autoreactive T cell responses.

Authors:  Benoit Melchior; Shweta S Puntambekar; Monica J Carson
Journal:  Neurochem Int       Date:  2006-06-08       Impact factor: 3.921

5.  The growth compromised HSV-2 mutant DeltaRR prevents kainic acid-induced apoptosis and loss of function in organotypic hippocampal cultures.

Authors:  Michael D Gober; Jennifer M Laing; Scott M Thompson; Laure Aurelian
Journal:  Brain Res       Date:  2006-10-03       Impact factor: 3.252

Review 6.  Microglia as a pharmacological target in infectious and inflammatory diseases of the brain.

Authors:  R Bryan Rock; Phillip K Peterson
Journal:  J Neuroimmune Pharmacol       Date:  2006-06       Impact factor: 4.147

Review 7.  A rose by any other name? The potential consequences of microglial heterogeneity during CNS health and disease.

Authors:  Monica J Carson; Tina V Bilousova; Shweta S Puntambekar; Benoit Melchior; Jonathan M Doose; Iryna M Ethell
Journal:  Neurotherapeutics       Date:  2007-10       Impact factor: 7.620

8.  Apoptosis of oligodendrocytes in the central nervous system results in rapid focal demyelination.

Authors:  Andrew V Caprariello; Saisho Mangla; Robert H Miller; Stephen M Selkirk
Journal:  Ann Neurol       Date:  2012-09       Impact factor: 10.422

9.  Caspases as therapeutic targets in Alzheimer's disease: is it time to "cut" to the chase?

Authors:  Troy T Rohn; Elizabeth Head
Journal:  Int J Clin Exp Pathol       Date:  2008-06-10

Review 10.  Debris clearance by microglia: an essential link between degeneration and regeneration.

Authors:  H Neumann; M R Kotter; R J M Franklin
Journal:  Brain       Date:  2008-06-20       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.